Table 4.

Physical and functional impairments (PFI) among uterine cancer survivors

PFI Characteristic	n	% of 213
Lower Limb Lymphedemaa	77	36.2
Painb	48	22.5
Severe Fatiguec	12	5.6
Pelvic floor symptoms
Severe Bladder/Urinary symptomsd	8	3.8
Severe Bowel symptomse	2	0.9
Severe Pelvic symptomsf	3	1.4
Number of above PFIs per Participant
0	100	47.0
1	89	41.8
2	15	7.0
3	6	2.8
4	2	0.9
5	1	0.5
TOTAL	213	100.0

^aLymphedema: ≥5 self-reported symptoms on GCLQ.

^bPain: BPI pain severity or pain interference scale score ≥5 (scale: 0–10).

^cFatigue: FSI composite fatigue score ≥80 (scale: 0–134).

^dBladder/urinary symptoms: Average impact on UDI-6 (PFDI) ≥75 (scale: 0–100) or average impact on UIQ-7 (PFIQ) ≥66.7 (scale: 0–100).

^eBowel symptoms : Average impact on CRADI-8 (PFDI) ≥75 (scale: 0–100) or average impact on CRAIQ-7 (PFIQ) ≥66.7 (scale: 0–100).

^fPelvic symptoms: Average impact on POPDI-6 (PFDI) ≥75 (scale: 0–100) or average impact on POPIQ-7 (PFIQ) ≥66.7 (scale: 0–100).

^gOne or more of above complications, includes: pain, fatigue, lower limb lymphedema, urinary/bladder symptoms, bowel symptoms, pelvic symptoms.